Characterisation of the active/de-active transition of mitochondrial complex I  by Galkin, Alexander
S4 –Complex I
S4.L1
Characterisation of the active/de-active transition of mitochondrial
complex I
Alexander Galkin
Queen's University Belfast, UK
E-mail address: a.galkin@qub.ac.uk
NADH:ubiquinone oxidoreductase or complex I is a major con-
tributor to ATP generation in mitochondria. It is also a source of
detrimental free radicals as well as a target for oxidative damage
by them. An unusual feature of complex I from several species is
the active/de-active (A/D) transition [1,2]. The A-form catalyses
the rapid physiological reaction of NADH oxidation and sponta-
neously converts to the dormant D-form within minutes if the
enzyme is idle (e.g. during ischaemia). The D-form can undergo
re-activation during slow catalytic turnover(s). Cys-39 of the
mitochondrially-encoded subunit ND3 becomes exposed upon de-
activation [2]. The A/D transition plays an important role in tissue
response to hypoxia, therefore deactivation of the enzyme is one
of the key mitochondrial events during ischaemia. The mechanism
of deactivation is currently unknown, but we identiﬁed two new
subunits involved in a conformational change during the A/D
transition: ND1 and 39 kDa (NDUFA9) [2]. Most likely, de-
activation is a result of concerted structural rearrangement of
several subunits located in the region of the quinone binding site
which leads to disruption of the terminal electron transfer. We
suggested a physiological role of maintaining the enzyme in the
D-form during the ischaemic period. Accumulation of the D-form
could decrease the initial burst of respiration followed by ROS
formation after reoxygenation. Thus, the A/D transition could be
an intrinsic mechanism for decreasing oxidative damage during
an early phase of reoxygenation. However, Cys-39 of the ND3
subunit, exposed in the D-form, is susceptible to modiﬁcation by
ROS and nitric oxide metabolites. Modiﬁcation arrests re-activa-
tion of the D-form and inhibits the enzyme. The nature of thiol
modiﬁcation deﬁnes reversibility, re-activation dynamics, effect
on mitochondrial ATP-production and therefore, outcome follow-
ing ischaemia–reperfusion injury. Modulation of the A/D equilib-
rium of complex I in situ could ameliorate ischaemia/reperfusion
damage. Progress towards further characterisation will be
accessed and regulatory implications of the A/D transition in situ
discussed.
References
[1] A. Vinogradov, V. Grivennikova, The mitochondrial complex I:
Progress in understanding of catalytic properties, IUBMB Life 52
(2001) 129-134.
[2] M. Babot, A. Birch, P. Labarbuta, A. Galkin, Characterisation of the
active/de-active transition of mitochondrial complex I, Biochim.
Biophys. Acta 1837 (2014), 1082–1092.
doi:10.1016/j.bbabio.2014.05.044
S4.L2
Modeling pathogenic mtDNA mutations in bacteria for probing
their functional consequences in complex I with special reference
to proton pumping efﬁciency
Ilmo Hassinena, Jukka Pätsia, Marko Kervinenb
aFaculty of Biochemistry andMolecularMedicine, University of Oulu, Finland
bDepartment of Ophthalmology, Institute of Clinical Medicine,
University of Oulu, Finland
E-mail address: ilmo.hassinen@oulu.ﬁ
Mitochondrial Complex I is a target of pathogenicmutations because
seven of its subunits are encoded in mtDNA. Modeling of mtDNA
mutations in bacteria offers a reasonably stable platform for experi-
mentation. Therefore we tested mutations by means of modeling them
in Escherichia coli NDH-1, the bacterial counterpart of mitochondrial
Complex I. A knockout E. coli NUO subunit strain was produced and
complemented in-trans with an expression plasmid containing the
wild-type or mutated gene. Deamino-NADH oxidation and membrane
energization were monitored simultaneously by spectrophotometry
using Neutral Red as a probe in inverted membrane vesicles. This
allowed the determination of proton pump stoichiometry and mem-
brane leak parameters by means of curve ﬁtting with numerical
integration of a model equation throughout the d-NADH oxidation
pulse. Mutation in E24 of the human ND1 subunit causes an LHON/
MELAS overlap syndrome. The E. coli counterpart of ND1-E24 is NUOH-
E36. Its elimination caused a 95% inhibition of d-NADH oxidation and
zeroed the proton pumping. An E36D replacement approximately
halved the d-NADH oxidation rate and the proton pumping stoichiom-
etry. Elimination ofNUOH-E157 in a transmembrane helix halved the d-
NADHoxidation capacity but it did not affect proton pumping, although
the T. thermophilus homolog NQO8-E163 has been suggested to be
involved in proton translocation. ND6 is a hotspot of mtDNAmutations.
M64, Y59 and A72 are sites of pathogenic mutations and were studied
in E. coliNUOJ for effects on proton pumping. Mutations in all three sites
resulted in marked decrease in d-NADH oxidation in E. coli. The most
effective mutations affecting proton pumping were the Y59F mutation
and the elimination of M72, which actually is a counterpart of the
human A72. The ND4L/NUOK subunit contains two highly conserved
glutamates in the middle of transmembrane helices. Elimination of
these carboxylic moieties killed the enzyme. Putting the twin carboxyls
to a single helix by replacing E72 with Q72 and I39 with D39 halved
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